Get started
Author

Giulia Spallone

Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas
2011 · Elisabetta Botti, Giulia Spallone, et al. · Proceedings of the National Academy of Sciences · 172
Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab
2013 · M. Talamonti, E. Botti, et al. · British Journal of Dermatology · 148
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias
2010 · Francesca Moretti, Barbara Marinari, et al. · Journal of Clinical Investigation · 144
PDF
Programmed cell death in the skin
2015 · Antonio Costanzo, Francesca Fausti, et al. · The International Journal of Developmental Biology · 55
PDF
Efalizumab
2011 · Marina Talamonti, Giulia Spallone, et al. · Expert Opinion on Drug Safety · 47
PDF
A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy
2007 · R. Saraceno, L. Citarella, et al. · Clinical and Experimental Dermatology · 43
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146
2017 · Maria Cristina Rapanotti, Elena Campione, et al. · Cell Death Discovery · 40
PDF
Cutaneous mastocytosis: A dermatological perspective
2020 · Cosimo Di Raimondo, Ester Del Duca, et al. · Australasian Journal of Dermatology · 36
Psoriasis, from Pathogenesis to Therapeutic Strategies: IL-21 as a Novel Potential Therapeutic Target
2012 · Elisabetta Botti, Giulia Spallone, et al. · Current Pharmaceutical Biotechnology · 28
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature
2020 · Elena Campione, Monia Di Prete, et al. · Chemotherapy · 27
PDF
Targeted Therapy in Nonmelanoma Skin Cancers
2011 · Giulia Spallone, Elisabetta Botti, et al. · Cancers · 26
PDF
Stem–Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients
2020 · Maria Cristina Rapanotti, Elena Campione, et al. · Frontiers in Molecular Biosciences · 19
PDF
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities
2019 · Giulia Spallone, Pietro Sollena, et al. · Dermatologic Therapy · 16
PDF
Baseline neutrophil/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinoma
2021 · Cosimo Di Raimondo, Raffaele Dante Caposiena Caro, et al. · International Journal of Dermatology · 12
Detection of Adalimumab and Anti‐Adalimumab Levels by ELISA : Clinical Considerations
2014 · Barbara Marinari, Elisabetta Botti, et al. · Drug Development Research · 11
Signaling Pathways in Squamous Cancer
2010 · COSTANZO, ANTONIO, SPALLONE, GIULIA, et al. · Springer eBooks · 11
Constitutional Intraepidermal Ascent of Melanocytes: A Potential Pitfall in the Diagnosis of Melanocytic Lesions
2012 · Katrin Kerl, Werner Kempf, et al. · Archives of Dermatology · 9
Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy
2008 · Antonio Costanzo, Marina Talamonti, et al. · Dermatology · 9
Efficacy of Vismodegib in pigmented basal cell carcinoma: Appearances are deceiving
2020 · Cosimo Di Raimondo, Mauro Mazzeo, et al. · Dermatologic Therapy · 7
PDF
Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression
2020 · Maria Cristina Rapanotti, Tara Mayte Suarez Viguria, et al. · Cancer Treatment and Research Communications · 7
PDF
Patients with Moderate to Severe Plaque Psoriasis: One Year after the European Medicines Agency Recommendation of Efalizumab Suspension
2011 · M. Talamonti, M. Teoli, et al. · Dermatology · 7
Clinical determinants of complete response to vismodegib in locally advanced basal cell carcinoma: a multicentre experience
2021 · M.C. Fargnoli, C. Pellegrini, et al. · Journal of the European Academy of Dermatology and Venereology · 4
The Role of IL-21 in Chronic Inflammatory Skin Diseases
2012 · Elisabetta Botti, Andreea N. Boca, et al. · Current Dermatology Reports · 4
PDF
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis
2008 · Antonio Costanzo, Mark S. Talamonti, et al. · 4
Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study
2025 · Mario Valenti, Sara Di Giulio, et al. · Dermatology Reports · 3
Works count: 42
Citation count: 903
H-index: 13
I10-index: 16
Year
Topic
Type